Retrieve available abstracts of 55 articles: HTML format
Single Articles
October 2025
TOGAWA K, Matsumoto S, Deng L, Jin M, et al DOPAnization of alpha-synuclein exacerbates dopaminergic neurodegeneration in the
substantia nigra.
Neurosci Lett. 2025;865:138354. PubMedAbstract available
August 2025
WANG J, Hou J, Du M, Hou X, et al The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in
Parkinson's disease through the Nrf2/HMOX1 pathway.
Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338. PubMedAbstract available
July 2025
DENG X, Zheng W, Xu H, Yang Y, et al Genetic analysis of TMEM230 variants in Han Chinese patients with Parkinson's
disease.
Neurosci Lett. 2025 Jul 29:138334. doi: 10.1016/j.neulet.2025.138334. PubMedAbstract available
May 2025
SUGIYAMA K, Kuroiwa M, Shuto T, Hwang S, et al Subregion-specific suppression of dopamine D1 receptor expression prevents
L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease.
Neurosci Lett. 2025 May 25:138273. doi: 10.1016/j.neulet.2025.138273. PubMedAbstract available
CORTES-ALTAMIRANO JL, Alfaro-Rodriguez A, Morraz-Varela A, Reyes-Long S, et al Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain
caused by a persistent painful stimulus in Parkinsonian rats.
Neurosci Lett. 2025;859-861:138270. PubMedAbstract available
January 2025
ORTEGA A, Laville A, Padilla-Orozco M, Parrado Y, et al Cortical beta oscillation in brain slices of hemi parkinsonian mice.
Neurosci Lett. 2025;849:138128. PubMedAbstract available
October 2024
ZHANG J, Dong M, Li Z, Li Z, et al Association of plasma neurofilament light chain and Lipoprotein-related
phospholipase A2 with motor subtypes of Parkinson's disease.
Neurosci Lett. 2024 Oct 16:138011. doi: 10.1016/j.neulet.2024.138011. PubMedAbstract available
VILLAMAR-FLORES CI, Rodriguez-Violante M, Abundes-Corona A, Alatriste-Booth V, et al Association between alterations in sleep spindles and cognitive decline in
persons with Parkinson's disease.
Neurosci Lett. 2024;842:138006. PubMedAbstract available
September 2024
BAGWELL E, Shin M, Henkel N, Migliaccio D, et al 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a
model for Parkinson's Disease.
Neurosci Lett. 2024;842:137991. PubMedAbstract available
JIANG M, Liu Y, Cao Y, Liu Y, et al Auxiliary diagnostic method of Parkinson's disease based on eye movement analysis
in a virtual reality environment.
Neurosci Lett. 2024 Sep 2:137956. doi: 10.1016/j.neulet.2024.137956. PubMedAbstract available
August 2024
ZHANG W, Peng H, Yang D, Song G, et al Absence of motor impairments or pathological changes in TMEM230 knockout rats.
Neurosci Lett. 2024;837:137921. PubMedAbstract available
FAN X, Tang Y, Wei Z, Shi F, et al Mitochondrial dysfunction and NDUFS3: Insights from a PINK1(B9) Drosophila model
in Parkinson's disease pathogenesis.
Neurosci Lett. 2024 Aug 3:137917. doi: 10.1016/j.neulet.2024.137917. PubMedAbstract available
July 2024
CHEN J, Meng Q, Zhang Y, Liang Y, et al TrueTH: A user-friendly deep learning approach for robust dopaminergic neuron
detection.
Neurosci Lett. 2024;836:137871. PubMedAbstract available
HE Q, Zhou Y, Jin J, Tian Q, et al Association between NEK1 gene polymorphisms and the potential risk of sporadic
Parkinson's disease in the Chinese Northern Han population: A case-control study.
Neurosci Lett. 2024 Jul 18:137913. doi: 10.1016/j.neulet.2024.137913. PubMedAbstract available
June 2024
MENG Q, Chen J, Liang Y, Zhang X, et al miR-142-3p alleviates neuronal apoptosis in Parkinson's disease via negatively
regulating C9orf72.
Neurosci Lett. 2024 Jun 26:137887. doi: 10.1016/j.neulet.2024.137887. PubMedAbstract available
MARANO M, Altavista MC, Cassetta E, Brusa L, et al The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD
post-hoc study.
Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850. PubMedAbstract available
April 2024
ZAMEER F, Jain P, Khan K, Pramod Kumar P, et al Unraveling the regulatory landscape of Parkinson disease: A molecular symphony of
miRNAs, transcription factors, and high-risk genes.
Neurosci Lett. 2024 Apr 25:137792. doi: 10.1016/j.neulet.2024.137792. PubMedAbstract available
March 2024
LI Z, Liu J, Miao X, Ge S, et al Reorganization of structural brain networks in Parkinson's disease with postural
instability/gait difficulty.
Neurosci Lett. 2024 Mar 19:137736. doi: 10.1016/j.neulet.2024.137736. PubMedAbstract available
February 2024
SARKAR S, Biswas A, Ansari S, Choudhury S, et al Association of dopamine receptor D3 polymorphism with Levodopa-induced
Dyskinesia: A study on Parkinson's disease patients from India.
Neurosci Lett. 2024;825:137706. PubMedAbstract available
ADLER CH, Serrano GE, Shill HA, Driver-Dunckley E, et al Symmetry of synuclein density in autopsied Parkinson's disease submandibular
glands.
Neurosci Lett. 2024;825:137702. PubMedAbstract available
TAKIZAWA S, Ohuchi K, Fujimaki A, Ito T, et al Effects of alpha7 nicotinic acetylcholine receptor agonist against
alpha-synuclein-induced neurotoxicity.
Neurosci Lett. 2024;823:137654. PubMedAbstract available
CAKIR M, Sacmaci H The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and
acute ischemic stroke: A preliminary study.
Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683. PubMedAbstract available
January 2024
LIU H, Gong Z, Li Z, Ye T, et al Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia
nigra pars reticulata of mouse.
Neurosci Lett. 2024;818:137555. PubMedAbstract available
December 2023
HU Q, Xu L, Liu X, Wang Y, et al Adenosine A(2A) receptor antagonist KW6002 protects against A53T mutant
alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson's
disease mice by restoring autophagic flux.
Neurosci Lett. 2023 Dec 27:137610. doi: 10.1016/j.neulet.2023.137610. PubMedAbstract available
HUANG W, Wang Y, Huang W Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to
activate Wnt signaling pathway.
Neurosci Lett. 2023 Dec 22:137608. doi: 10.1016/j.neulet.2023.137608. PubMedAbstract available
RAJAN S, Sood A, Jain R, Kamatham PT, et al Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin
dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
Neurosci Lett. 2023;820:137596. PubMedAbstract available
November 2023
BILISTER EGILMEZ C, Azak Pazarlar B, Alper Erdogan M, Erbas O, et al Neuroprotective effect of dexpanthenol on rotenone-induced Parkinson's disease
model in rats.
Neurosci Lett. 2023 Nov 29:137575. doi: 10.1016/j.neulet.2023.137575. PubMedAbstract available
GUO F, Kang J, Xu J, Wei S, et al Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in
complex diseases of nervous system.
Neurosci Lett. 2023;817:137513. PubMedAbstract available
SINGH A, Panhelainen A, Voutilainen MH Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic
midbrain culture for modeling dopamine neuron degeneration.
Neurosci Lett. 2023;816:137510. PubMedAbstract available
PAN Y, Zong Q, Li G, Wu Z, et al Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by
decreasing hippocampal neurogenesis and pathologically affecting amygdala
circuits.
Neurosci Lett. 2023;816:137490. PubMedAbstract available
October 2023
MONAGHAN AS, Hooyman A, Dibble LE, Mehta SH, et al Cognitive Predictors of Responsiveness to Reactive Step Training in People with
Parkinson's Disease at Fall-Risk.
Neurosci Lett. 2023;817:137517. PubMedAbstract available
September 2023
STATZ M, Schleuter F, Weber H, Kober M, et al Subthalamic nucleus deep brain stimulation does not alter growth factor
expression in a rat model of stable dopaminergic deficiency.
Neurosci Lett. 2023;814:137459. PubMedAbstract available
GENG X, Zou Y, Li J, Li S, et al Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling
pathway and promote neuronal autophagy to alleviate PD symptoms.
Neurosci Lett. 2023;814:137437. PubMedAbstract available
August 2023
HEO EJ, Lee Y, Hyung Seo M, Yeo S, et al Association between SGK1 and alpha-synuclein in skeletal muscle in an MPTP-induced
Parkinson's disease model.
Neurosci Lett. 2023 Aug 25:137464. doi: 10.1016/j.neulet.2023.137464. PubMedAbstract available
KAPLAN ALGIN A, Tomruk C, Gozde Aslan C, Saban Akkurt S, et al Effects of ozone treatment to the levels of neurodegeneration biomarkers after
rotenone induced rat model of Parkinson's disease.
Neurosci Lett. 2023;814:137448. PubMedAbstract available
HE P, Gao Y, Shi L, Li Y, et al Motor progression phenotypes in early-stage Parkinson's Disease: A clinical
prediction model and the role of glymphatic system imaging biomarkers.
Neurosci Lett. 2023 Aug 8:137435. doi: 10.1016/j.neulet.2023.137435. PubMedAbstract available
TAN Z, Lin Y, Zhou M, Guo W, et al Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic
Parkinson's disease in Han population in Southern China.
Neurosci Lett. 2023 Aug 4:137426. doi: 10.1016/j.neulet.2023.137426. PubMedAbstract available
July 2023
TIAN Q, Sun X, Li C, Yang Y, et al CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern
Chinese Han population: A case-control study.
Neurosci Lett. 2023;812:137400. PubMedAbstract available
LI Y, Li F, Liu X, Zu J, et al Association between serum neurofilament light chain levels and sleep disorders in
patients with Parkinson's disease.
Neurosci Lett. 2023 Jul 10:137394. doi: 10.1016/j.neulet.2023.137394. PubMedAbstract available
JIN H, Shen H, Liu C, Wang L, et al Decreased Serum BDNF Contributes to the Onset of REM Sleep Behavior Disorder in
Parkinson's Disease Patients.
Neurosci Lett. 2023 Jul 7:137380. doi: 10.1016/j.neulet.2023.137380. PubMedAbstract available
June 2023
HWAN SHIN J, Ah Shin D, Young Lee C, Jin Chang H, et al Inability to suppress head rotation during the saccade test as a clinical
biomarker for cognitive dysfunction in Parkinson's disease.
Neurosci Lett. 2023 Jun 22:137356. doi: 10.1016/j.neulet.2023.137356. PubMedAbstract available
ZHENG Q, Ma P, Yang P, Zhai S, et al Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in
Parkinson's disease.
Neurosci Lett. 2023 Jun 10:137346. doi: 10.1016/j.neulet.2023.137346. PubMedAbstract available
May 2023
WANG X, Wei W, Bai Y, Shen Y, et al Intrinsic Brain Activity Alterations in Patients With Parkinson's disease.
Neurosci Lett. 2023 May 15:137298. doi: 10.1016/j.neulet.2023.137298. PubMedAbstract available
April 2023
ZHANG X, Zhong X, Wang L, Li H, et al Effects of soluble TREM2 on motor progression in Parkinson's disease.
Neurosci Lett. 2023 Apr 25:137277. doi: 10.1016/j.neulet.2023.137277. PubMedAbstract available
ZHANG X, Li L, Qi L, Fu Y, et al Distribution pattern of iron deposition in the basal ganglia of different motor
subtypes of Parkinson's disease.
Neurosci Lett. 2023 Apr 13:137249. doi: 10.1016/j.neulet.2023.137249. PubMedAbstract available
SHIDA TKF, de Oliveira CEN, da Silva Fragoso de Campos D, Los Angeles E, et al Effect of freezing of gait and dopaminergic medication in the biomechanics of
lower limbs in the gait of patients with Parkinson's disease compared to
neurologically healthy.
Neurosci Lett. 2023;806:137250. PubMedAbstract available
MURAKAMI Y, Nishijima H, Nakamura T, Furukawa T, et al Altered amantadine effects after repetitive treatment for l-dopa-induced
involuntary movements in a rat model of Parkinson's disease.
Neurosci Lett. 2023;806:137248. PubMedAbstract available
DONG L, Chang Q, Ma J, Liu C, et al Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in
Parkinson's disease patients.
Neurosci Lett. 2023;804:137219. PubMedAbstract available
MA C, Wei X, Wang F, Zhang T, et al Tumor necrosis factor alpha-induced protein 3 mediates inflammation and neuronal
autophagy in Parkinson's disease via the NFkappaB and mTOR pathways.
Neurosci Lett. 2023 Apr 3:137223. doi: 10.1016/j.neulet.2023.137223. PubMedAbstract available
MORRISON S, Reilly N, Schussler E, Kerr G, et al The effect of standing posture on amplitude and variability of postural tremor in
Parkinson's disease.
Neurosci Lett. 2023 Apr 3:137220. doi: 10.1016/j.neulet.2023.137220. PubMedAbstract available
YUAN M, Du N, Song Z Primary motor area-related injury of anterior central gyrus in Parkinson's
disease with dyskinesia: a study based on MRS and Q-Space.
Neurosci Lett. 2023 Apr 3:137224. doi: 10.1016/j.neulet.2023.137224. PubMedAbstract available
March 2023
GOMEZ-MARTIN A, Fuentes JM, Jordan J, Galindo MF, et al Detection of rare Genetic Variations in the promoter regions of the ATG16L gene
in Parkinson's patients.
Neurosci Lett. 2023 Mar 21:137195. doi: 10.1016/j.neulet.2023.137195. PubMedAbstract available
LI W, Pan X, Li M, Ling L, et al Impact of age on the rotenone-induced sporadic Parkinson's disease model using
Drosophila melanogaster.
Neurosci Lett. 2023 Mar 13:137187. doi: 10.1016/j.neulet.2023.137187. PubMedAbstract available
February 2023
OMAR AHMAD S, Longhurst J, Stiles D, Downard L, et al A meta-analysis of exercise intervention and the effect on Parkinson's Disease
Symptoms.
Neurosci Lett. 2023 Feb 28:137162. doi: 10.1016/j.neulet.2023.137162. PubMedAbstract available
CARNEY AE, Clarke C, Pratt WE Administration of neuropeptide Y into the rat nucleus accumbens shell, but not
core, attenuates the motivational impairment from systemic dopamine receptor
antagonism by alpha-flupenthixol.
Neurosci Lett. 2023;797:137069. PubMedAbstract available